Decreased CD5(+) B Cells in Active ANCA Vasculitis and Relapse after Rituximab

BACKGROUND AND OBJECTIVES: B cell significance in ANCA disease pathogenesis is underscored by the finding that ANCA alone can cause disease in mouse models and by the effectiveness of rituximab as therapy in ANCA-small vessel vasculitis (ANCA-SVV). To avoid infections and adverse events from therapy...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bunch, Donna O’Dell, McGregor, JulieAnne G., Khandoobhai, Nirmal B., Aybar, Lydia T., Burkart, Madelyn E., Hu, Yichun, Hogan, Susan L., Poulton, Caroline J., Berg, Elisabeth A., Falk, Ronald J., Nachman, Patrick H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2013
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3586963/
https://ncbi.nlm.nih.gov/pubmed/23293123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.03950412
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak